| Literature DB >> 28392536 |
S H M P Wimalasena1, Gee-Wook Shin2, Sabrina Hossain1, Gang-Joon Heo1.
Abstract
To investigate the potential enterotoxicity and antimicrobial resistance of aeromonads from pet turtles as a risk for human infection, one hundred and two Aeromonas spp. were isolated from the feces, skin and rearing environments of pet turtles and identified by biochemical and gyrB sequence analyses. Aeromonas enteropelogenes was the predominant species among the isolates (52.9%) followed by A. hydrophila (32.4%), A. dharkensis (5.9%), A. veronii (4.9%) and A. caviae (3.9%). Their potential enterotoxicities were evaluated by PCR assays for detecting genes encoding cytotoxic enterotoxin (act) and two cytotonic enterotoxins (alt and ast). 75.8% of A. hydrophila isolates exhibited the act+/alt+/ast+ genotype, whereas 94.4% of A. enteropelogenes isolates were determined to be act-/alt-/ast-. In an antimicrobial susceptibility test, most isolates were susceptible to all tested antibiotics except amoxicillin, ampicillin, cephalothin, chloramphenicol and tetracycline. Non-susceptible isolates to penicillins (ampicillin and amoxicillin) and fluoroquinolones (ciprofloxacin and norfloxacin) were frequently observed among the A. enteropelogenes isolates. Few isolates were resistant to imipenem, amikacin, ceftriaxone and cefotaxime. Collectively, these results suggest that pet turtles may pose a public health risk of infection by enterotoxigenic and antimicrobial resistant Aeromonas strains.Entities:
Keywords: Aeromonas species; antimicrobial resistance; enterotoxin genes; pet turtles; yrB
Mesh:
Substances:
Year: 2017 PMID: 28392536 PMCID: PMC5447983 DOI: 10.1292/jvms.16-0493
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Sequence of oligonucleotide primers used in this study to detect three virulence genes
| Name of gene | Primer sequence | Product size (bp) | Length (bp) | Tm (°C) |
|---|---|---|---|---|
| F: AGAAGGTGACCACCACCAAGAACA | 232 | 24 | 65 | |
| R: AACTGACATCGGCCTTGAACTC | 24 | |||
| F: TGACCCAGTCCTGGCACGGC | 442 | 20 | 64 | |
| R: GGTGATCGATCACCACCAGC | 20 | |||
| F: TCTCCATGCTTCCCTTCCACT | 331 | 21 | 63 | |
| R: GTGTAGGGATTGAAGAAGCCG | 21 |
Distribution of Aeromonas species isolated from pet turtles and their environment based on gyrB sequencing
| Turtle name | Species | Source (No. of isolates) |
|---|---|---|
| African sideneck turtle | Soil (1) | |
| Skin (2), feces (2) and water (1) | ||
| Alligator snapping turtle | Skin (1) | |
| Skin (1), soil (1) and water (1) | ||
| Feces (2) | ||
| Chinese stripe-necked turtle | Feces (2) | |
| Skin (1) and feces (1) | ||
| Skin (5), feces (1) and water (1) | ||
| Skin (4), feces (3) and soil (1) | ||
| Feces (1) | ||
| Common musk turtle | Skin (3), soil (1) and water (1) | |
| Feces (3) | ||
| Northern Chinese softshell turtle | Water (1) | |
| Skin (2), feces (2) and soil (1) | ||
| Peninsula cooter | Soil (1) and water (1) | |
| Skin (2) and feces (3) | ||
| Skin (1) | ||
| Red belly cooter | Skin (1), feces (1) and soil (1) | |
| Skin (1) and feces (1) | ||
| River cooter | Feces (1) | |
| Feces (3) | ||
| Skin (7), feces (4), water (1) and soil (1) | ||
| Skin (1), feces (3) and soil (1) | ||
| Water (1) | ||
| Western painted turtle | Skin (3), feces (3), water (1) and soil (1) | |
| Yellow belly slider | Feces (1) | |
| Skin (5), feces (4), water (1) and soil (1) | ||
Prevalence of Aeromonas strains having certain combinations of virulence genes
| Gene combinations | Number (%) of positive strains for analyzed combination | Total positive strains | ||||
|---|---|---|---|---|---|---|
| (n=4) | (n=6) | (n=54) | (n=33) | (n=5) | ||
| - | - | 1 (1.9) | - | 5 (100) | 6 (5.9) | |
| - | 5 (83.3) | - | - | - | 5 (4.9) | |
| 1 (25.0) | - | 2 (3.7) | - | - | 3 (2.9) | |
| - | - | - | 1 (3.0) | - | 1 (1.0) | |
| - | - | - | 7 (21.2) | - | 7 (6.9) | |
| - | - | - | 25 (75.8) | - | 25 (24.5) | |
| Total | 1 (25.0) | 5 (83.3) | 3 (5.6) | 33 (100) | 5 (100) | 47 (46.1) |
Distribution of susceptible (S), intermediate (I) and resistance (R) strains of each Aeromonas species isolated from turtle and their environment
| Antimicrobial agents | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (n=4) | (n=6) | (n=54) | (n=33) | (n=5) | ||||||||||||
| S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | ||
| Penicillins | ||||||||||||||||
| Amoxicillin (10 | 0 | 0 | 4 | 0 | 0 | 6 | 33 | 0 | 21 | 1 | 0 | 32 | 0 | 0 | 5 | |
| Ampicillin (10 | 0 | 0 | 4 | 0 | 0 | 6 | 32 | 0 | 22 | 2 | 0 | 31 | 0 | 0 | 5 | |
| Cephalosporins | ||||||||||||||||
| Cephalothin (30 | 0 | 0 | 4 | 0 | 0 | 6 | 0 | 0 | 54 | 15 | 0 | 18 | 1 | 0 | 4 | |
| Ceftrioxone (30 | 3 | 0 | 1 | 2 | 1 | 3 | 52 | 0 | 2 | 26 | 3 | 4 | 4 | 1 | 0 | |
| Cefoxitin (30 | 2 | 0 | 2 | 2 | 0 | 4 | 46 | 3 | 5 | 27 | 3 | 3 | 4 | 0 | 1 | |
| Cefotaxime (30 | 4 | 0 | 0 | 1 | 0 | 5 | 49 | 5 | 0 | 33 | 0 | 0 | 5 | 0 | 0 | |
| Carbapenems | ||||||||||||||||
| Imipenem (10 | 3 | 0 | 1 | 6 | 0 | 0 | 54 | 0 | 0 | 32 | 0 | 1 | 5 | 0 | 0 | |
| Meropenem (10 | 4 | 0 | 0 | 6 | 0 | 0 | 54 | 0 | 0 | 33 | 0 | 0 | 5 | 0 | 0 | |
| Aminoglycosides | ||||||||||||||||
| Amikacin (30 | 3 | 0 | 1 | 6 | 0 | 0 | 54 | 0 | 0 | 33 | 0 | 0 | 5 | 0 | 0 | |
| Streptomycin (10 | 1 | 1 | 2 | 4 | 0 | 2 | 47 | 6 | 1 | 31 | 1 | 1 | 4 | 0 | 1 | |
| Gentamycin (10 | 2 | 1 | 1 | 6 | 0 | 0 | 54 | 0 | 0 | 33 | 0 | 0 | 5 | 0 | 0 | |
| Tobramycin (10 | 2 | 0 | 2 | 6 | 0 | 0 | 54 | 0 | 0 | 33 | 0 | 0 | 5 | 0 | 0 | |
| Fluoroquinolone | ||||||||||||||||
| Ciprofloxacin (5 | 2 | 0 | 2 | 2 | 2 | 2 | 13 | 30 | 11 | 32 | 0 | 1 | 5 | 0 | 0 | |
| Norfloxacin (10 | 2 | 0 | 2 | 0 | 0 | 6 | 10 | 25 | 19 | 33 | 0 | 0 | 3 | 0 | 2 | |
| Others | ||||||||||||||||
| Aztreonam (30 | 4 | 0 | 0 | 6 | 0 | 0 | 47 | 1 | 6 | 32 | 1 | 0 | 5 | 0 | 0 | |
| Chloramphenicol (30 | 0 | 0 | 4 | 0 | 0 | 6 | 5 | 0 | 49 | 7 | 0 | 26 | 0 | 0 | 5 | |
| Nalidixic acid (30 | 3 | 0 | 1 | 4 | 0 | 2 | 44 | 6 | 4 | 24 | 3 | 6 | 3 | 1 | 1 | |
| Tetracycline (30 | 3 | 0 | 1 | 2 | 0 | 4 | 4 | 0 | 50 | 15 | 1 | 17 | 2 | 0 | 3 | |
| Trimethoprim / sulfamethoxazole (1.25/23.75 | 2 | 0 | 2 | 0 | 0 | 6 | 44 | 6 | 4 | 26 | 6 | 1 | 4 | 0 | 1 | |
S, susceptible; I, intermediate; R, resistance.